[Code of Federal Regulations]

[Title 42, Volume 4]

[Revised as of October 1, 2006]

From the U.S. Government Printing Office via GPO Access

[CITE: 42CFR505.3]



[Page 1112]

 

                         TITLE 42--PUBLIC HEALTH

 

  CHAPTER IV--CENTERS FOR MEDICARE & MEDICAID SERVICES, DEPARTMENT OF 

                  HEALTH AND HUMAN SERVICES (CONTINUED)

 

PART 505_ESTABLISHMENT OF THE HEALTH CARE INFRASTRUCTURE IMPROVEMENT 

 

                         Subpart A_Loan Criteria

 

Sec.  505.3  Definitions.



    For purposes of this subpart, the following definitions apply:

    Eligible project means the project of a qualifying hospital that is 

designed to improve the health care infrastructure of the hospital, 

including construction, renovation, or other capital improvements.

    Entity is an entity described in section 501(c)(3) of the Internal 

Revenue Code of 1986 and exempt from tax under section 501(a) of the 

code. An entity must also have at least one existing memorandum of 

understanding or affiliation agreement with a hospital located in the 

State in which the entity is located and retains clinical outpatient 

treatment for cancer on site as well as laboratory research, education, 

and outreach for cancer in the same facility.

    Outreach programs mean formal cancer programs for teaching, 

diagnostic screening, therapy or treatment, prevention, or interventions 

to enhance the health and knowledge of their designated population(s).

    Qualifying hospital means a hospital as defined at section 1861(e) 

of the Act (42 U.S,C. 1395x(e)) or an entity (as defined in this 

section) that is engaged in research in the causes, prevention, and 

treatment of cancer; and is either designated as a cancer center for the 

National Cancer Institute; or designated by the State legislature as the 

official cancer institute of the State before December 8, 2003.

    Unique research resources means resources that are used for the 

purpose of discovering or testing options related to the causes, 

prevention, and treatment of cancer.



[70 FR 57374, Sept. 30, 2005, as amended at 71 FR 48143, Aug. 18, 2006]